Forward Therapeutics Announces $50 Million Series A Financing To Advance Next-Generation Small Molecule Immune Therapies
Nov 08, 2023•about 2 years ago
Amount Raised
$50 Million
Round Type
series a
Palm Beach GardensBiopharmaTherapeuticsPharmaceuticalBiotechnologyHealth CareInvestors
Orbi MedRa Capital ManagementBvf Partners Lp
Description
Forward Therapeutics, Inc., a biopharmaceutical company developing next-generation small molecule therapies for chronic immunological and inflammatory disorders, today announced a $50 million Series A financing. The financing was led by BVF Partners LP with participation from other leading life sciences investors RA Capital Management and OrbiMed.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech